Cargando…
Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?
The central goal of cancer immunotherapy is to control tumors through the mobilization of the patient's immune system. Vaccines targeting the Her2/neu proto-oncogene have been tested with some early encouraging responses in breast cancer. However, a more effective set of vaccines targeting spec...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446337/ https://www.ncbi.nlm.nih.gov/pubmed/22643384 http://dx.doi.org/10.1186/bcr3184 |